Publication:
The EQ-5D-5L Valuation study in Thailand

dc.contributor.authorJuntana Pattanaphesajen_US
dc.contributor.authorMontarat Thavorncharoensapen_US
dc.contributor.authorJuan Manuel Ramos-Goñien_US
dc.contributor.authorSirinart Tongsirien_US
dc.contributor.authorLily Ingsrisawangen_US
dc.contributor.authorYot Teerawattananonen_US
dc.contributor.otherKasetsart Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherMahasarakham Universityen_US
dc.contributor.otherEuroQol Research Foundationen_US
dc.contributor.otherHealth Intervention and Technology Assessment Programen_US
dc.date.accessioned2019-08-23T11:44:15Z
dc.date.available2019-08-23T11:44:15Z
dc.date.issued2018-09-03en_US
dc.description.abstract© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Background: At present, health technology assessment (HTA) guidelines of many countries including Thailand have recommended EQ-5D as the preferred method for assessing utility. This study aims to generate an EQ-5D-5L value set based on societal preferences of Thai population. Methods: A 1,207 representative sample was recruited using a stratified multi-stage quota sampling technique. Face-to-face, computer-assisted interviews using the EuroQol Valuation Technology (EQ-VT) software were employed. To elicit preference score, each respondent was asked to value health states using composite time trade-off (cTTO), and discrete choice experiment (DCE). All data were integrated and analyzed using a hybrid regression model to estimate the value set. Results: Characteristics of 1,207 participants were generally similar to those of Thai general population. The coefficients generated from a hybrid model were logically consistent. The second best value is 0.9436 for health state 11121 and the worst state (55555) value is −0.4212. Mobility shows the greatest impact to utility decrement. Conclusions: Our study developed a Thai value set for EQ-5D using hybrid model. The findings from this study are of important to facilitate health technology assessment studies to inform policy decision-making as well as to promote the use of EQ-5D-5L in various health research in Thailand.en_US
dc.identifier.citationExpert Review of Pharmacoeconomics and Outcomes Research. Vol.18, No.5 (2018), 551-558en_US
dc.identifier.doi10.1080/14737167.2018.1494574en_US
dc.identifier.issn17448379en_US
dc.identifier.issn14737167en_US
dc.identifier.other2-s2.0-85049627841en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46332
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049627841&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThe EQ-5D-5L Valuation study in Thailanden_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049627841&origin=inwarden_US

Files

Collections